Showing results (201-210 of 401) with videos related to
Sort By:
Pageof 41
Frontiers in Immunology|August 30, 2018
Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34+-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter StudyEmilia Salzmann-Manrique, Melanie Bremm, Sabine Huenecke, et al.Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|March 20, 2026
Clinical Development Programme of the Innovative Mesenchymal Stromal Cell Product MSC-FFM/MC0518 for Steroid-Refractory Acute Graft-Versus-Host Disease: Design of 2 Randomised Controlled Trials in Adult and Paediatric PatientsRobert Zeiser, Halvard Bönig, Elena Osswald, et al.Cytotherapy|November 27, 2016
Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphomaSarah Oelsner, Miriam E Friede, Congcong Zhang, et al.Nature Medicine|May 5, 2015
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptorsAdrienne H Long, Waleed M Haso, Jack F Shern, et al.Journal for Immunotherapy of Cancer|May 9, 2022
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulationElizabeth M Holland, John C Molina, Kniya Dede, et al.British Journal of Haematology|August 2, 2021
The incidence and type of cancer in patients with ataxia-telangiectasia via a retrospective single-centre studyShahrzad Bakhtiar, Emilia Salzmann-Manrique, Helena Donath, et al.Frontiers in Immunology|November 16, 2020
ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk RhabdomyosarcomaMichael Merker, Juliane Wagner, Hermann Kreyenberg, et al.Best Practice & Research. Clinical Haematology|September 20, 2011
Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in childrenPatrick Schlegel, Heiko-Manuel Teltschik, Matthias Pfeiffer, et al.Best Practice & Research. Clinical Haematology|September 20, 2011
Natural killer cell activity influences outcome after T cell depleted stem cell transplantation from matched unrelated and haploidentical donorsPeter Lang, Matthias Pfeiffer, Heiko-Manuel Teltschik, et al.Frontiers in Pediatrics|August 8, 2014
SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination TherapyEva Rettinger, Andreas Glatthaar, Behnaz Ahangarian Abhari, et al.Pageof 41